Copertina

A Comparative Analysis of the Pharmacodynamic and Pharmacokinetic Properties of 2 Controlled‐Release Formulations Versus a Marketed Orlistat Product

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Stefan Grudén, Anders Forslund, Helena Litorp, Sandra Kuusk, Göran Alderborn, Arvid Söderhäll, Ulf Holmbäck
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Clinical Pharmacology in Drug Development
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The Supportive Effect of Acarbose to Orlistat in Weight Management—A Randomized, Double‐Blind, Multiarm Phase 2 Trial
di: Ulf Holmbäck, et al.
Pubblicazione: (2025)

Intravenous Ganaxolone: Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability in Healthy Adults
di: Maciej Gasior, et al.
Pubblicazione: (2024)

Safety, Pharmacokinetics, and Pharmacodynamics of Etrasimod: Single and Multiple Ascending Dose Studies in Healthy Adults
di: Caroline A. Lee, et al.
Pubblicazione: (2024)

Clinical Pharmacology of GP40321 (Insulin Glulisine Biosimilar): Pharmacokinetic and Pharmacodynamic Comparability in a Hyperinsulinemic‐Euglycemic Clamp Procedure
di: Ekaterina Koksharova, et al.
Pubblicazione: (2024)

Extrapolation of Midazolam Disposition in Neonates Using Physiological‐Based Pharmacokinetic/Pharmacodynamic Modeling
di: Tangping Zhao, et al.
Pubblicazione: (2025)

Pharmacokinetics and Bioequivalence of a Novel Extended‐Release Formulation of Methylphenidate Hydrochloride for Attention‐Deficit/Hyperactivity Disorder
di: Ann C. Childress, et al.
Pubblicazione: (2025)

Pharmacokinetics and Bioequivalence of a Generic Ticagrelor 90‐mg Formulation Versus the Innovator Product in Healthy White Subjects Under Fasting Conditions
di: Simona Rizea‐Savu, et al.
Pubblicazione: (2024)

Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Recombinant Neorudin, a New Anticoagulant Drug in Patients With Acute Coronary Syndrome
di: Yu‐bin Liu, et al.
Pubblicazione: (2024)

Population Pharmacokinetic and Pharmacodynamic Modeling of Romiplostim Biosimilar GP40141 and Reference Product in Healthy Volunteers to Evaluate Biosimilarity
di: Igor Makarenko, et al.
Pubblicazione: (2024)

Pharmacokinetics, Receptor Occupancy, and Pharmacodynamics of Obexelimab Following Intravenous Administration in Adult Healthy Volunteers and in Patients With Rheumatoid Arthritis
di: Xiaodong Wang, et al.
Pubblicazione: (2025)

Comparison of the Pharmacokinetics of Three Budesonide Formulations in Healthy Chinese Subjects
di: Tengrui Yin, et al.
Pubblicazione: (2025)

Comparative Pharmacokinetics and Bioequivalence of 2 Formulations of Bosentan Dispersible Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions
di: Zhaoming Huang, et al.
Pubblicazione: (2025)

Pharmacokinetics and Bioequivalence of 2 Oral Formulations of Vildagliptin in Healthy Chinese Subjects
di: Mengli Tian, et al.
Pubblicazione: (2024)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Neonatal Fc Receptor Inhibitor Rozanolixizumab: An Ethnic Sensitivity Study in Healthy Japanese, Chinese, and White Participants
di: Assem el Baghdady, et al.
Pubblicazione: (2024)

Comparative Bioequivalence and Food Effect of Two Formulations of 30‐mg Nifedipine Controlled‐Release Tablets in Healthy Chinese Adults
di: Huizi Zhang, et al.
Pubblicazione: (2024)

Pharmacokinetic and Pharmacodynamic Principles and Concepts Remain Relevant in the Era of Artificial Intelligence and Machine Learning
di: Keith A. Rodvold
Pubblicazione: (2026)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses and Dose Titration of Bexicaserin in Healthy Participants in a Randomized, Double‐Blind, Placebo‐Controlled Study
di: Jonathan Williams, et al.
Pubblicazione: (2025)

Effect of a High‐Fat Meal on the Pharmacokinetics of an Immediate Release Atogepant Tablet
di: Ramesh R. Boinpally, et al.
Pubblicazione: (2024)

Bioequivalence and Pharmacokinetic Evaluation of Gliclazide Modified‐Release Tablets in Healthy Chinese Volunteers
di: Kejia Fu, et al.
Pubblicazione: (2026)

Pharmacokinetics and Bioequivalence Evaluation of Trazodone Hydrochloride Sustained‐Release Tablets in Healthy Chinese Volunteers
di: Jingyan Wang, et al.
Pubblicazione: (2024)

Combined Immediate‐Release and Extended‐Release Formulation of Sodium Valproate Provides Stable Plasma Levels for Inhibition of Histone Deacetylation
di: Nikhil Ahuja, et al.
Pubblicazione: (2025)

A Phase 1 Dose‐Escalation, Food Effect, and Drug–Drug Interaction Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MALT1 Inhibitor, SGR‐1505, in Healthy Volunteers
di: Vipul K. Gupta, et al.
Pubblicazione: (2026)

Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan and Amlodipine Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions
di: Yu‐Ying Xu, et al.
Pubblicazione: (2025)

Bioequivalence and Pharmacokinetics of Ibuprofen Extended‐Release Capsules in Healthy Chinese Volunteers Under Fasting and Postprandial Conditions
di: Mingqi Chen, et al.
Pubblicazione: (2025)

Pharmacokinetic Profile and Comparative Bioavailability of an Oral Fixed‐Dose Combination of Metformin and Acetylsalicylic Acid (Aspirin)
di: Lourdes Garza‐Ocañas, et al.
Pubblicazione: (2024)

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Bexicaserin in Healthy Participants: A First‐in‐Human Randomized, Double‐Blind, Placebo‐Controlled Single Ascending Dose Escalation Phase 1 Study
di: Rosa Chan, et al.
Pubblicazione: (2025)

Steady‐State Pharmacokinetic Properties of TNX‐102 SL, a Sublingual Tablet Formulation of Cyclobenzaprine Hydrochloride (HCl), With Daily Dosing in Healthy Volunteers: A Randomized, Open‐Label Trial
di: Gregory M. Sullivan, et al.
Pubblicazione: (2026)

Comparability of Elezanumab Safety, Tolerability, and Pharmacokinetics in Healthy Japanese, Chinese, and White Participants
di: Hari V. Kalluri, et al.
Pubblicazione: (2024)

Pharmacokinetics, Bioequivalence, and Safety of Diclofenac Sodium Sustained‐Release Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions
di: Biao Sun, et al.
Pubblicazione: (2026)

Pharmacokinetics and Bioequivalence of two Empagliflozin Tablet Formulations: Results From a Randomized, Open‐Label, Crossover Study in Fasting Healthy Volunteers
di: Kar Ming Yee, et al.
Pubblicazione: (2025)

Apixaban Pharmacokinetics and Bioequivalence of Two Tablet Formulations: A Randomized, Open‐Label, Crossover Study, Fasting Condition in Healthy Indonesian Volunteers
di: Chuei Wuei Leong, et al.
Pubblicazione: (2024)

Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Oral Formulations of Calcium Dobesilate Capsules in Healthy Chinese Volunteers Under Fasting and Fed Conditions
di: Yanrong Wang, et al.
Pubblicazione: (2024)

Pharmacokinetics and Safety of a Fixed‐Dose Combination of Alogliptin and Extended‐Release Metformin Under Fasting and/or Fed Conditions in Healthy Adults
di: Ji Hye Song, et al.
Pubblicazione: (2025)

Comparative Pharmacodynamic Bioequivalence Study of Enoxaparin Sodium 100 mg/1 mL Solution for Injection in Prefilled Syringe in Healthy Volunteers Under Fasting Conditions
di: Naba Kumar Talukdar, et al.
Pubblicazione: (2025)

Evaluation of Acarbose Bioequivalence in Healthy Chinese Populations Using Novel Pharmacodynamic End Points
di: Linling Que, et al.
Pubblicazione: (2024)

Pharmacokinetic and Safety Comparison of Fixed‐Dose Combination of Cilostazol/Rosuvastatin (200 + 20 mg) Versus Concurrent Administration of the Separate Components in Healthy Adults
di: Jae Hoon Kim, et al.
Pubblicazione: (2024)

A Randomized Phase 1 Study Evaluating Pharmacokinetics, Safety, and Tolerability of a High‐Concentration, Long‐Acting Cabotegravir Formulation in Adults Without HIV
di: Kelong Han, et al.
Pubblicazione: (2025)

Comparative Bioequivalence Study of 2 Clopidogrel 75‐mg Tablet Formulations in Moroccan Volunteers
di: Aimen El Orche, et al.
Pubblicazione: (2024)

Comparative Pharmacokinetics and Bioequivalence of Two Sodium Valproate Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions
di: Yuan Liu, et al.
Pubblicazione: (2025)

Safety, Tolerability, and Pharmacokinetics of Single‐ and Multiple‐Ascending Doses of Sunobinop in Healthy Participants
di: Alessandra Cipriano, et al.
Pubblicazione: (2024)